Cargando…
Efficacy and safety of recombinant Mycobacterium tuberculosis ESAT-6 protein for diagnosis of pulmonary tuberculosis: A phase II trial
BACKGROUND: This study aimed to determine the efficacy and safety of recombinant Mycobacterium tuberculosis ESAT-6 protein for diagnosis of pulmonary tuberculosis (TB). MATERIAL/METHODS: A phase II trial was performed in 158 patients with pulmonary TB (145 initially-treated and 13 re-treated) and 13...
Autores principales: | Sun, Qing-Feng, Xu, Miao, Wu, Jin-Guo, Chen, Bao-Wen, Du, Wei-Xin, Ding, Ji-Guang, Shen, Xiao-Bing, Su, Cheng, Wen, Jin-Sheng, Wang, Guo-Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836599/ https://www.ncbi.nlm.nih.gov/pubmed/24217560 http://dx.doi.org/10.12659/MSM.889425 |
Ejemplares similares
-
Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein
por: Du, Wei-Xin, et al.
Publicado: (2013) -
A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice
por: Jiang, Qingtao, et al.
Publicado: (2013) -
Author Correction: A novel recombinant DNA vaccine encoding
Mycobacterium tuberculosis ESAT-6 and FL protects against
Mycobacterium tuberculosis challenge in mice
por: Jiang, Qingtao, et al.
Publicado: (2022) -
Macrophage Immune Response Suppression by Recombinant Mycobacterium tuberculosis Antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 Fusion Proteins
por: Seghatoleslam, Atefeh, et al.
Publicado: (2016) -
Development of ESAT-6 Based Immunosensor for the Detection of Mycobacterium tuberculosis
por: Omar, Rishabh Anand, et al.
Publicado: (2021)